Physician profile
Barbara Levy
NPI 1184629859
$719,455.99
in general payments reported to CMS, 2019-2025
8 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $28K · 2021: $68K · 2022: $194K · 2023: $208K · 2024: $144K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $413K · Acquisitions: $4,777 · Food and Beverage: $315 · Travel and Lodging: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $412,778.00 |
| Acquisitions | $4,777.29 |
| Food and Beverage | $314.50 |
| Travel and Lodging | $275.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $522,611.47 | 2022-2025 | |
| Acessa Health INC. | $109,936.06 | 2019-2025 | Acessa Provu System |
| Hologic INC | $56,804.80 | 2020-2024 | |
| Amag Pharmaceuticals, INC. | $9,858.72 | 2021-2022 | |
| Abbvie INC. | $9,405.44 | 2019-2023 | |
| Myovant Sciences INC. | $5,350.00 | 2022 | |
| Cytyc Surgical Products, LLC | $4,950.00 | 2023 | Acessa Provu System |
| Hologic Sales and Service, LLC | $539.50 | 2023-2025 | Novasure, None, Acessa Provu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.